This article investigates the effects of low-frequency repetitive transcranial magnetic stimulation (rTMS) on functional connectivity in schizophrenia patients, aiming to elucidate the genetic and molecular mechanisms involved.
This randomized clinical trial evaluates the neurobehavioral responses associated with treatment outcomes for generalized anxiety disorder, employing a novel approach-avoidance conflict task to predict responses.
Through larger samples of patient data from specialized clinics and multicenter studies, researchers and clinicians aim to better comprehend the origins of the condition.
This clinical trial assesses the efficacy of esketamine nasal spray in treating Korean participants suffering from treatment-resistant depression.
Johns Hopkins psychiatrists point to the need for earlier, faster-acting treatments.
This systematic review explores the neuroimaging findings related to the psychosocial effects of the COVID-19 pandemic, focusing on mental health outcomes and the neurobiological mechanisms underlying these effects.
The research investigates the effects of cannabidiol on alcohol dependence and withdrawal, highlighting its potential neuroprotective benefits in specific brain regions.
This article examines the dynamics of RNA modifications associated with major depressive disorder and their implications for suicide risk, providing insights into potential biomarkers and therapeutic targets.
Experts in the Department of Psychiatry and Behavioral Sciences plan to streamline clinical approaches and better understand each patient’s unique neurobiology.
This study is focused on evaluating the effect of transcranial stimulation targeting the right amygdala over a period of six weeks in participants with major depressive disorder.
This study investigates the effectiveness of metacognitive training techniques for improving psychiatric symptoms in patients diagnosed with disorders including depression.
BMJ Open takes us on a stroll through the garden of knowledge as they look at pioneering new strategies to treat metabolic disorders in children by blending precision medicine with age-old traditions.
Tonix Pharmaceuticals serves up the results of their Phase 3 RESILIENT trial, announcing breaks from the norm with their TNX-102 SL proving some punchy pain relief for fibromyalgia, all tucked neatly into the prestigious journal 'Pain Medicine'.
This article discusses the impact of genetic factors on brain criticality and cognition, highlighting how these elements interact to influence cognitive processes.
This article discusses the implications of the SC–VTA pathway in relation to neurodevelopmental processes associated with autism spectrum disorder.
This research examines the differential roles of microglial and macrophagic C3ar1 signaling in modulating synaptic and behavioral outcomes associated with stress.